Molecule News and Research

RSS

Finding overturns long held ideas about how cells build proteins

Writing in the May 28 issue of Cell, Johns Hopkins researchers report that four critical components of cells' protein-building machine don't do what scientists had long assumed.

27 May 2004

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Results of a new study published in the current issue of the New England Journal of Medicine show that in patients who have chronic hepatitis C, genotype 1 -- the most common form of the disease and difficult to treat successfully -- non-Hispanic whites achieved one of the highest response rates reported to date, but response rates in African Americans were significantly lower.

27 May 2004

Research may lead to elimination of surface-induced thrombus formation

A University of Missouri-Rolla researcher’s investigation into how proteins adhere to surfaces may lead the elimination of surface-induced thrombus formation, a phenomenon known to cause blood clots in artificial arteries, valves and veins.

26 May 2004

New technology to measure the sensitivity of nerve fibers that wire up the brain during development

Researchers at Georgetown University have developed a novel technology to precisely measure the sensitivity of nerve fibers that wire up the brain during development. Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon’s route to its desired destination in the brain.

26 May 2004

3 or 4 glasses of wine a week can kill cancer cells

It’s well known that drinking red wine in moderation can have some health benefits, mainly attributed to a compound called resveratrol. Now, scientists at the University of Virginia Health System have discovered how.

25 May 2004

Zengen announces positive results of treatment for vaginal yeast infection

Zengen Inc. announced today positive phase I/II results for its proprietary molecule CZEN-002 for the treatment of vulvovaginal candidiasis (VVC), commonly known as vaginal yeast infection.

25 May 2004

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Nexxus, the West of Scotland Bioscience Network will hold the second event of the Horizons in Biomedicine Series today at 6.30pm at the Glasgow Science Centre.

25 May 2004

Toxoplasma gondii discovery may help fight against malaria

University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that’s crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.

25 May 2004

Possible new second-generation multiple sclerosis therapy

Scientists from Genencor International, Inc., have demonstrated in an in vivo model that a new variant of recombinant interferon-beta reduces the immunological response to the protein.

25 May 2004

X-ray beams could kick start genes into fighting cancer

X-ray beams could kick start genes into fighting cancer as an exciting new way of targeting therapy against the disease, according to new research in the Journal of Gene Medicine.

25 May 2004

Researchers have isolated a protein receptor in chickens responsible for transferring antibodies from mother to offspring

Howard Hughes Medical Institute (HHMI) researchers have isolated a protein receptor in chickens that is responsible for transferring antibodies from mother to offspring - a function critical to bestowing a temporary immunity that protects the young against infection until their own immune systems begin functioning.

24 May 2004

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Vertex Pharmaceuticals Incorporated has announced that it has expanded its drug discovery and development collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation.

24 May 2004

Scientists have genetically engineered a mouse with extraordinary resistance to bowel cancer

Scientists have genetically engineered a mouse with extraordinary resistance to bowel cancer, delegates at the Cancer Research UK senior researchers' conference in Harrogate will hear today.

24 May 2004

Research shows that treatment with nitric oxide after storage may dramatically improve the viability of transplanted livers

About 5,000 liver transplants are performed annually in the United States, and a key factor ensuring success is maintaining a healthy donor organ that can function effectively in the recipient. However, transplanted livers typically incur substantial damage when blood flow is restored to the organ after the transplant.

24 May 2004

Researchers have developed technology to precisely measure the sensitivity of nerve fibers that wire up the brain during development

Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon's route to its desired destination in the brain. Their findings are described in the June issue of Nature Neuroscience.

23 May 2004

New study of tumor genetics may help to treat patients with head and neck cancer

Head and neck tumors account for more than 40,000 new cancers annually in the United States. The most common of these is squamous cell carcinoma. Prognosis is based largely on location and size of the tumor, and if the cancer has spread, or metastasized, to lymph nodes and distant sites in the body.

19 May 2004

Multimillion-dollar electron microscope unveils shapes of viruses and proteins

With a multimillion-dollar electron microscope and computer programs that can pick out the shapes of structures only six atoms wide, Dr. Wah Chiu and his colleagues at Baylor College of Medicine in Houston are attempting to explain the intricate structures of viruses and proteins.

19 May 2004

Molecule News and Research

Finding overturns long held ideas about how cells build proteins

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Research may lead to elimination of surface-induced thrombus formation

New technology to measure the sensitivity of nerve fibers that wire up the brain during development

3 or 4 glasses of wine a week can kill cancer cells

Zengen announces positive results of treatment for vaginal yeast infection

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Toxoplasma gondii discovery may help fight against malaria

Possible new second-generation multiple sclerosis therapy

X-ray beams could kick start genes into fighting cancer

Researchers have isolated a protein receptor in chickens responsible for transferring antibodies from mother to offspring

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Scientists have genetically engineered a mouse with extraordinary resistance to bowel cancer

Research shows that treatment with nitric oxide after storage may dramatically improve the viability of transplanted livers

Researchers have developed technology to precisely measure the sensitivity of nerve fibers that wire up the brain during development

New study of tumor genetics may help to treat patients with head and neck cancer

Multimillion-dollar electron microscope unveils shapes of viruses and proteins

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Bio-optical CD could screen patients for thousands of disease markers while they wait

A new synthetic chemical may provide framework for future drugs to treat brain-based ailments

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News